Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information remained secret.
What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials
Written by
in
Clinical Trials, Drugs (Pharmaceuticals), Eisai Co Ltd, Elderly, Eli Lilly and Company, Food and Drug Administration, Genetics and Heredity, Government Accountability Office, Hemorrhagic Stroke, Institute for Clinical and Economic Review, Kisunla, Leqembi (Drug), Medicine and Health, Novartis AG, Retirement Communities and Assisted Living, United States, Villages, The (Fla)